Christopher J. Senner - 05 Jun 2024 Form 4 Insider Report for Quince Therapeutics, Inc. (QNCX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	QNCX	Employee Stock Option (right to buy)	Award	$0	+27,000		$0.000000	27,000	05 Jun 2024	Common Stock	27,000	$0.8200	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	100% of the shares subject to this stock option will vest on the one-year anniversary of the grant date.